Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition

Authors

Julie Irving•James Allan•Cornelia Eckert

Journal

Blood

Published

September 25, 2014

Sign in to comment

Add a comment...

Supporters

Support the authors with ResearchCoin

Topics

DOI

10.1182/blood-2014-04-531871

License

Unknown License

Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition - Comments